Literature DB >> 21454715

Citrullination of inhibitor of growth 4 (ING4) by peptidylarginine deminase 4 (PAD4) disrupts the interaction between ING4 and p53.

Qin Guo1, Walter Fast.   

Abstract

Gene expression is regulated by a number of interrelated posttranslational modifications of histones, including citrullination. For example, peptidylarginine deminase 4 (PAD4) converts peptidyl arginine to citrulline in histone H3 and can repress gene expression. However, regulation of gene expression through citrullination of non-histone proteins is less well defined. Herein, we identify a tumor suppressor protein, inhibitor of growth 4 (ING4), as a novel non-histone substrate of PAD4. ING4 is known to bind p53 via its nuclear localization signal (NLS) region and to enhance transcriptional activity of p53. We show that PAD4 preferentially citrullinates ING4 in the same NLS region and thereby disrupts the interaction between ING4 and p53. A citrulline-mimicking Arg-NLS-Gln ING4 mutant, which has all Arg residues in the NLS mutated to Gln, loses its affinity for p53, can no longer promote p53 acetylation, and results in repression of downstream p21 expression. In addition, we found that citrullination leads to increased susceptibility of ING4 to degradation, likely impacting p53-independent pathways as well. These findings elucidate an interaction between posttranslational citrullination, acetylation, and methylation and highlight an unusual mechanism whereby citrullination of a non-histone protein impacts gene regulation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21454715      PMCID: PMC3089551          DOI: 10.1074/jbc.M111.230961

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

1.  Deacetylation of p53 modulates its effect on cell growth and apoptosis.

Authors:  J Luo; F Su; D Chen; A Shiloh; W Gu
Journal:  Nature       Date:  2000-11-16       Impact factor: 49.962

2.  Deimination of myelin basic protein. 1. Effect of deimination of arginyl residues of myelin basic protein on its structure and susceptibility to digestion by cathepsin D.

Authors:  L B Pritzker; S Joshi; J J Gowan; G Harauz; M A Moscarello
Journal:  Biochemistry       Date:  2000-05-09       Impact factor: 3.162

3.  Downregulation and translocation of nuclear ING4 is correlated with tumorigenesis and progression of head and neck squamous cell carcinoma.

Authors:  Xiao-han Li; Keiji Kikuchi; Yang Zheng; Akira Noguchi; Hiroyuki Takahashi; Takeshi Nishida; Shinji Masuda; Xiang-hong Yang; Yasuo Takano
Journal:  Oral Oncol       Date:  2011-03       Impact factor: 5.337

4.  hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase.

Authors:  H Vaziri; S K Dessain; E Ng Eaton; S I Imai; R A Frye; T K Pandita; L Guarente; R A Weinberg
Journal:  Cell       Date:  2001-10-19       Impact factor: 41.582

5.  Histone deimination antagonizes arginine methylation.

Authors:  Graeme L Cuthbert; Sylvain Daujat; Andrew W Snowden; Hediye Erdjument-Bromage; Teruki Hagiwara; Michiyuki Yamada; Robert Schneider; Philip D Gregory; Paul Tempst; Andrew J Bannister; Tony Kouzarides
Journal:  Cell       Date:  2004-09-03       Impact factor: 41.582

6.  Structural basis for Ca(2+)-induced activation of human PAD4.

Authors:  Kyouhei Arita; Hiroshi Hashimoto; Toshiyuki Shimizu; Katsuhiko Nakashima; Michiyuki Yamada; Mamoru Sato
Journal:  Nat Struct Mol Biol       Date:  2004-07-11       Impact factor: 15.369

7.  An Arg/Lys-->Gln mutant of recombinant murine myelin basic protein as a mimic of the deiminated form implicated in multiple sclerosis.

Authors:  Ian R Bates; David S Libich; D Denise Wood; Mario A Moscarello; George Harauz
Journal:  Protein Expr Purif       Date:  2002-07       Impact factor: 1.650

8.  Human PAD4 regulates histone arginine methylation levels via demethylimination.

Authors:  Yanming Wang; Joanna Wysocka; Joyce Sayegh; Young-Ho Lee; Julie R Perlin; Lauriebeth Leonelli; Lakshmi S Sonbuchner; Charles H McDonald; Richard G Cook; Yali Dou; Robert G Roeder; Steven Clarke; Michael R Stallcup; C David Allis; Scott A Coonrod
Journal:  Science       Date:  2004-09-02       Impact factor: 47.728

9.  p29ING4 and p28ING5 bind to p53 and p300, and enhance p53 activity.

Authors:  Masayuki Shiseki; Makoto Nagashima; Remy M Pedeux; Mariko Kitahama-Shiseki; Koh Miura; Shu Okamura; Hitoshi Onogi; Yuichiro Higashimoto; Ettore Appella; Jun Yokota; Curtis C Harris
Journal:  Cancer Res       Date:  2003-05-15       Impact factor: 12.701

Review 10.  The calcium ion and cell death.

Authors:  S Orrenius; P Nicotera
Journal:  J Neural Transm Suppl       Date:  1994
View more
  46 in total

Review 1.  Protein Arginine Deiminases and Associated Citrullination: Physiological Functions and Diseases Associated with Dysregulation.

Authors:  Erin E Witalison; Paul R Thompson; Lorne J Hofseth
Journal:  Curr Drug Targets       Date:  2015       Impact factor: 3.465

2.  Inhibiting protein arginine deiminases has antioxidant consequences.

Authors:  Erin E Witalison; Xiangli Cui; Anne B Hofseth; Venkataraman Subramanian; Corey P Causey; Paul R Thompson; Lorne J Hofseth
Journal:  J Pharmacol Exp Ther       Date:  2015-01-29       Impact factor: 4.030

3.  Citrullinated calreticulin potentiates rheumatoid arthritis shared epitope signaling.

Authors:  Song Ling; Erika N Cline; Timothy S Haug; David A Fox; Joseph Holoshitz
Journal:  Arthritis Rheum       Date:  2013-03

4.  Autoantibodies against P29ING4 are associated with complex regional pain syndrome.

Authors:  N T Baerlecken; R Gaulke; N Pursche; T Witte; M Karst; M Bernateck
Journal:  Immunol Res       Date:  2019-12       Impact factor: 2.829

5.  PAD1 promotes epithelial-mesenchymal transition and metastasis in triple-negative breast cancer cells by regulating MEK1-ERK1/2-MMP2 signaling.

Authors:  Hao Qin; Xiaoqiu Liu; Fujun Li; Lixia Miao; Tingting Li; Boqun Xu; Xiaofei An; Aaron Muth; Paul R Thompson; Scott A Coonrod; Xuesen Zhang
Journal:  Cancer Lett       Date:  2017-08-24       Impact factor: 8.679

6.  Anticancer peptidylarginine deiminase (PAD) inhibitors regulate the autophagy flux and the mammalian target of rapamycin complex 1 activity.

Authors:  Yuji Wang; Pingxin Li; Shu Wang; Jing Hu; Xiangyun Amy Chen; Jianhui Wu; Megan Fisher; Kira Oshaben; Na Zhao; Ying Gu; Dong Wang; Gong Chen; Yanming Wang
Journal:  J Biol Chem       Date:  2012-05-17       Impact factor: 5.157

7.  SUMOylation of the ING1b tumor suppressor regulates gene transcription.

Authors:  Shankha Satpathy; Claire Guérillon; Tae-Sun Kim; Nicolas Bigot; Satbir Thakur; Shirin Bonni; Karl Riabowol; Rémy Pedeux
Journal:  Carcinogenesis       Date:  2014-06-05       Impact factor: 4.944

8.  Folded Conformation, Cyclic Pentamer, Nano-Structure and PAD4 Binding Mode of YW3-56.

Authors:  Haimei Zhu; Yuji Wang; Yaonan Wang; Shurui Zhao; Ming Zhao; Lin Gui; Wenyun Xu; Xiangyun Amy Chen; Yanming Wang; Shiqi Peng
Journal:  J Phys Chem C Nanomater Interfaces       Date:  2013-05-16       Impact factor: 4.126

9.  Inactivation of epidermal growth factor by Porphyromonas gingivalis as a potential mechanism for periodontal tissue damage.

Authors:  Krzysztof Pyrc; Aleksandra Milewska; Tomasz Kantyka; Aneta Sroka; Katarzyna Maresz; Joanna Kozieł; Ky-Anh Nguyen; Jan J Enghild; Anders Dahl Knudsen; Jan Potempa
Journal:  Infect Immun       Date:  2012-10-22       Impact factor: 3.441

Review 10.  Peptidylarginine deiminases in citrullination, gene regulation, health and pathogenesis.

Authors:  Shu Wang; Yanming Wang
Journal:  Biochim Biophys Acta       Date:  2013-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.